Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
Prot# ADMA-001: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Trial Evaluating the Safety and Efficacy of RI-001 in Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Severe RSV Illness
Ison, Michael G
(PD/PI)
Medicine, Infectious Diseases Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
8/18/08
→
8/18/11
Funding
ADMA Biologics, Inc.
(ADMA-001)
View all
View less